Pricing Log in Create free account

Cytosorbents Corporation (CTSO) vs Nano-X Imaging Ltd. (NNOX)

Cytosorbents Corporation and Nano-X Imaging Ltd. are both Medical Devices companies. Nano-X Imaging Ltd. is the larger, with a market value of $19.6M against $14.5M — 1.3× the size. Nano-X Imaging Ltd. grew revenue faster over the last twelve months: 31.5% against 3.07%. Cytosorbents Corporation has the higher net margin (−48.9% vs −747.2%) and the higher return on invested capital (−66.9% vs −168.6%). Across the 16 metrics below, Cytosorbents Corporation leads on 12 and Nano-X Imaging Ltd. on 4.

Valuation

Metric CTSO NNOX Medical Devices median
P/E n/m n/m 24.94
P/S 0.40 1.07 2.66
P/B n/m 0.23 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m 0.07 11.42
EV/Sales 0.75 (0.51) 2.76
Earnings yield (122.11%) (709.46%) (12.66%)
Free cash flow yield (63.17%) (310.38%) (7.18%)

Profitability

Metric CTSO NNOX Medical Devices median
Gross margin 71.61% (337.50%) 57.76%
Operating margin (34.74%) (765.62%) (14.84%)
Net margin (48.94%) (747.20%) (14.45%)
Free cash flow margin (25.32%) (333.22%) (5.70%)
Return on equity (336.17%) (98.98%) (10.56%)
Return on assets (42.38%) (84.82%) (17.26%)
Return on invested capital (66.90%) (168.62%) (5.22%)

Growth

Metric CTSO NNOX Medical Devices median
Revenue growth (TTM) 3.07% 31.52% 10.41%
EPS growth (last fiscal year) 65.79% (27.47%) 28.17%
Revenue growth, 5-year CAGR (2.00%) — 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTSO NNOX Medical Devices median
Debt to equity (22.96) 0.04 0.04
Current ratio 0.66 2.84 2.67
Net debt to EBITDA (0.85) 0.69 0.54

Dividend

Metric CTSO NNOX Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric CTSO NNOX Medical Devices median
Market cap 14.50m 19.56m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack